American Association for Cancer Research

Continuing Medical Education (CME)

Frontiers in Cancer Prevention Research 2013ACCREDITATION STATEMENT

The American Association for Cancer Research (AACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.


The AACR has designated this live activity for a maximum of 28.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit certification for individual sessions may vary, dependent upon compliance with the ACCME Accreditation Criteria. The final number of credits may vary from the maximum number indicated above.


Physicians and other health care professionals seeking AMA PRA Category 1 Credit(s)™ for this live continuing medical education activity must complete the online CME Request for Credit Survey by Wednesday, December 11, 2013. Certificates will only be issued to those who complete the survey. Your CME certificate will be sent to you via email after the completion of the activity.


In 2013, about 1,660,290 new cancer cases are expected to be diagnosed in the United States and just over 580,000 Americans are expected to die from the disease. According to the World Health Organization, at least one-third of all cancer cases are preventable by successful behavioral interventions such as smoking cessation and increased physical activity. Cancer screening increases the chance of early detection. Advances in technology, including genomics, informatics, imaging, and e-health have accelerated the pace of discovery, translation, and application of primary, secondary, and tertiary prevention strategies across all disciplines of cancer prevention research and clinical practice. These prevention strategies have the potential to have a major impact on reducing cancer incidence throughout the world. 

There is a need to bring together basic researchers, physicians, clinician-scientists, population scientists, and behavioral scientists to discuss the latest advances in cancer prevention research and educate physicians and health practitioners about how they can apply these advances to improve preventive care to individuals at risk for developing cancer. Therefore, the focus of this conference is to educate physicians on timely topics in cancer prevention, including appropriate screening tests and screening guidelines, risk assessment, vaccination strategies, behavioral interventions, and others. After participating in this CME activity, physicians should be able to:

  • Recognize and utilize technological advances to harness bioinformatics and medical informatics data for cancer prevention;
  • Articulate the role of microbiota and infections in cancer risk and the use of antimicrobials and vaccines for cancer prevention;
  • Critically assess the results of clinical trials designed to evaluate preventive interventions in populations at increased cancer risk;
  • Articulate tobacco-control science and public policy and utilize both in cancer prevention research and practice; and
  • Apply the most recent developments in cancer risk modification, early detection, and chemoprevention to clinical practice. 


It is the policy of the AACR that the information presented at AACR CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR will provide information that Scientific Program Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information will be made available in the Program/Proceedings of this conference.


This activity is supported by grants and will be disclosed at the activity. 


Please contact the Office of CME at (215) 440-9300 or